Pretreatment with Dexamethasone Increases Antitumor Activity of Carboplatin and Gemcitabine in Mice Bearing Human Cancer Xenografts

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Clinical Cancer Research

• Publication date

  2004-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-0829-3PMID 15014014
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A high-performance liquid chromatographic assay for CI-973, a new anticancer platinum diamine complex, in human plasma and urine ultrafiltrates

  2004cited by this paper
• Dexamethasone as a chemoprotectant in cancer chemotherapy: hematoprotective effects and altered pharmacokinetics and tissue distribution of carboplatin and gemcitabine

  2004cited by this paper
• Steroids decrease uptake of carboplatin in rat gliomas – Uptake improved by intracarotid infusion of bradykinin analog, RMP-7

  2004cited by this paper
• Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10.

  2003cited by this paper
• Hematopoietic Protection by Dexamethasone or Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Patients Treated With Carboplatin and Ifosfamide

  2003cited by this paper
• Supramol – a program for structure analysis of intercalates using molecular simulations: the structure of VOPO4·C6H4O2

  2002cited by this paper
• Anti-Tumor Efficacy of a Novel Antisense Anti-MDM2 Mixed-Backbone Oligonucleotide in Human Colon Cancer Models: p53-Dependent and p53-Independent Mechanisms

  2002cited by this paper
• Inflammation and cancer

  2002cited by this paper
• Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process.

  2002cited by this paper
• Antisense anti-MDM2 oligonucleotides as a novel approach to the treatment of glioblastoma multiforme.

  2002cited by this paper
• Clinical translation of angiogenesis inhibitors

  2002cited by this paper
• Pulmonary and lymph node metastasis is associated with primary tumor interstitial fluid pressure in human melanoma xenografts.

  2002cited by this paper
• Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy

  2001cited by this paper
• Combination of 1alpha,25-dihydroxyvitamin D(3) with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross-talk and Erk/Akt signaling.

  2001cited by this paper
• Potential mechanism for the effects of dexamethasone on growth of androgen-independent prostate cancer.

  2001cited by this paper
• Antisense anti-MDM2 oligonucleotides as a novel therapeutic approach to human breast cancer: in vitro and in vivo activities and mechanisms.

  2001cited by this paper
• Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer.

  2001cited by this paper
• T‐Cell Immunodeficiency Following Cytotoxic Antineoplastic Therapy: A Review

  2000cited by this paper
• Angiogenesis in cancer and other diseases

  2000cited by this paper
• Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1alpha.

  2000cited by this paper
• Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: Possible involvement of TNFα and IL‐1α

  2000cited by this paper
• Openings between defective endothelial cells explain tumor vessel leakiness.

  2000cited by this paper
• Dexamethasone pre-treatment interferes with apoptotic death in glioma cells.

  2000cited by this paper
• T-cell immunodeficiency following cytotoxic antineoplastic therapy: a review.

  1999cited by this paper
• Biological implications of macrophage infiltration in human tumor angiogenesis

  1999cited by this paper
• Antitumor activity and pharmacokinetics of a mixed-backbone antisense oligonucleotide targeted to the RIalpha subunit of protein kinase A after oral administration.

  1999cited by this paper
• Glucocorticoids regulate transendothelial fluid flow resistance and formation of intercellular junctions.

  1999cited by this paper
• Enhancement of 1,25-dihydroxyvitamin D3-mediated antitumor activity with dexamethasone.

  1998cited by this paper
• NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation.

  1998cited by this paper
• Reduction in Carboplatin Hematopoietic Toxicity in Tumor Bearing Mice: Comparative Mechanisms and Effects of Interleukin-1β and Corticosteroids

  1997cited by this paper
• Steroids decrease uptake of carboplatin in rat gliomas--uptake improved by intracarotid infusion of bradykinin analog, RMP-7.

  1997cited by this paper
• Carboplatin combined with amifostine, a bone marrow protectant, in the treatment of non-small-cell lung cancer: a randomised phase II study.

  1995cited by this paper
• Pharmacokinetics and tissue distribution in rats of an oligodeoxynucleotide phosphorothioate (GEM 91) developed as a therapeutic agent for human immunodeficiency virus type-1.

  1995cited by this paper
• Recombinant human interleukin-1 receptor antagonist protects early myeloid progenitors in a murine model of cyclophosphamide-induced myelotoxicity.

  1995cited by this paper
• Corticosteroid alteration of carboplatin-induced hematopoietic toxicity in a murine model.

  1995cited by this paper
• Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis.

  1995cited by this paper
• Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB Synthesis

  1995cited by this paper
• Corticosteroid modulation of interleukin-1 hematopoietic effects and toxicity in a murine system.

  1994cited by this paper
• Kinetic response of human marrow myeloid progenitor cells to in vivo treatment of patients with granulocyte colony-stimulating factor is different from the response to treatment with granulocyte-macrophage colony-stimulating factor.

  1994cited by this paper
• Regulation of cytokine expression by interferon-alpha in human bone marrow stromal cells: inhibition of hematopoietic growth factors and induction of interleukin-1 receptor antagonist.

  1994cited by this paper
• Protection of murine bone marrow by dexamethasone during cytotoxic chemotherapy.

  1994cited by this paper
• Recombinant transforming growth factor beta 1 and beta 2 protect mice from acutely lethal doses of 5-fluorouracil and doxorubicin

  1994cited by this paper
• Dexamethasone reduces the interstitial fluid pressure in a human colon adenocarcinoma xenograft.

  1993cited by this paper
• Relationship between circadian-dependent toxicity of 5-fluorodeoxyuridine and circadian rhythms of pyrimidine enzymes: possible relevance to fluoropyrimidine chemotherapy.

  1993cited by this paper
• [Hematopoietic growth factors].

  1993cited by this paper
• Short‐term administration of granulocyte‐macrophage colony stimulating factor decreases hematopoietic toxicity of cytostatic drugs

  1993cited by this paper
• Abrogating chemotherapy-induced myelosuppression by recombinant granulocyte-macrophage colony-stimulating factor in patients with sarcoma: protection at the progenitor cell level.

  1992cited by this paper
• [Hematopoietic growth factors. Biology and clinical applications].

  1992cited by this paper
• Demonstration of stem cell inhibition and myeloprotective effects of SCI/rhMIP1 alpha in vivo.

  1992cited by this paper
• Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo.

  1990cited by this paper
• Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF-beta.

  1990cited by this paper
• Chemoprotective effects of recombinant human IL-1 alpha in cyclophosphamide-treated normal and tumor-bearing mice. Protection from acute toxicity, hematologic effects, development of late mortality, and enhanced therapeutic efficacy.

  1990cited by this paper
• Transport of molecules in the tumor interstitium: a review.

  1987cited by this paper
• Effect of dexamethasone on vascular function in RIF-1 tumors.

  1986cited by this paper
• Receptor-mediated antiproliferative effects of corticosteroids in Lewis lung tumors.

  1984cited by this paper
• Correlation between glucocorticoid receptor content and the antiproliferative effect of dexamethasone in experimental solid tumors.

  1983cited by this paper
• Cancer: Principles and Practice of Oncology

  1983cited by this paper
• Corticosteroid effect on granulopoiesis in mice after cyclophosphamide.

  1977cited by this paper
• [Inflammation and cancer].

  1974cited by this paper
• Bone marrow failure.

  1954influential reference
• Protection of Murine Bone Marrow by Dexamethasone During Cytotoxic Chemotherapy

  year unknowncited by this paper

• Glucocorticoid receptor activated by dexamethasone promotes the chemoresistance and stemness of lung cancer.

  2025cites this paper
• Targeting inflammation in cancer therapy: from mechanistic insights to emerging therapeutic approaches

  2025cites this paper
• Inflammation and cancer: friend or foe?

  2024cites this paper
• Dexamethasone Suppresses IL-33-exacerbated Malignant Phenotype of U87MG Glioblastoma Cells via NF-κB and MAPK Signaling Pathways.

  2024cites this paper
• Engineered Nanomicelles inhibit the tumour progression via abrogating the prostaglandin-mediated immunosuppression.

  2024cites this paper
• Enhancing the solubility and potency of tetrahydrocurcumin as an anti-cancer agent using a β-cyclodextrin inclusion complex approach

  2024cites this paper
• Dexamethasone–tamoxifen combination exerts synergistic therapeutic effects in tamoxifen-resistance breast cancer cells

  2024cites this paper
• Bipyridine Ruthenium(II) Complexes with Halogen-Substituted Salicylates: Synthesis, Crystal Structure, and Biological Activity

  2023cites this paper
• Dexamethasone induces cancer mitigation and irreversible senescence in lung cancer cells via damaging cortical actin and sustained hyperphosphorylation of pRb.

  2023cites this paper
• Dexamethasone and overall survival and progression free survival in patients with newly diagnosed glioblastoma: a meta-analysis

  2023cites this paper
• Identification of corticosteroids as potential inhibitor against glycolytic enzyme hexokinase II role in cancer glycolysis pathway: a molecular docking study

  2023cites this paper
• Induction of SGK1 via glucocorticoid-influenced clinical outcome of triple-negative breast cancer patients

  2023cites this paper
• Toxic Effects of Gemcitabine and Paclitaxel Combination: Chemotherapy Drugs Exposure in Zebrafish

  2023cites this paper
• Inflammation targeted nanomedicines: patents and applications in cancer therapy.

  2022cites this paper
• Advantages and drawbacks of dexamethasone in glioblastoma multiforme.

  2022cites this paper
• How to Improve SBRT Outcomes in NSCLC: From Pre-Clinical Modeling to Successful Clinical Translation

  2022cites this paper
• Mechanisms behind context-dependent role of glucocorticoids in breast cancer progression

  2022cites this paper
• Surgical Stress and Cancer Progression: New Findings and Future Perspectives

  2022cites this paper
• The Sledgehammer in Precision Medicine: Dexamethasone and Immunotherapeutic Treatment of Glioma

  2021cites this paper
• Inflammation and tumor progression: signaling pathways and targeted intervention

  2021cites this paper
• Insufficient ablation promotes the metastasis of residual non-small cell lung cancer (NSCLC) cells via upregulating carboxypeptidase A4

  2021cites this paper
• Endocrine regulation of cancer stem cell compartments in breast tumors.

  2021cites this paper
• The solid tumor microenvironment—Breaking the barrier for T cells

  2021cites this paper
• Old and New Players of Inflammation and Their Relationship With Cancer Development

  2021cites this paper
• Influence of NSAIDs and methotrexate on CD73 expression and glioma cell growth

  2021cites this paper
• Nicaraven prevents the fast growth of inflamed tumors by an anti-inflammatory mechanism

  2021cites this paper
• Dexamethasone enhances the lung metastasis of breast cancer via a PI3K-SGK1-CTGF pathway

  2021cites this paper
• A patent review of anticancer glucocorticoid receptor modulators (2014-present)

  2020cites this paper
• Kinetics of Nuclear Uptake and Site-Specific DNA Cleavage during CRISPR-Directed Gene Editing in Solid Tumor Cells

  2020cites this paper
• Anti-Inflammatory Drugs as Anticancer Agents

  2020cites this paper
• Contribution of Hormones and Other Bioregulators to Tumor Ontopathogeny

  2020cites this paper
• Glucocorticoid Receptor Expression Predicts Good Outcome in response to Taxane-Free, Anthracycline-Based Therapy in Triple Negative Breast Cancer

  2020cites this paper
• Dexamethasone in Glioblastoma Multiforme Therapy: Mechanisms and Controversies

  2019cites this paper
• Enhancing solid tumor therapy with sequential delivery of dexamethasone and docetaxel engineered in a single carrier to overcome stromal resistance to drug delivery.

  2019cites this paper
• Experimental Animal Models for Lung Cancer

  2019cites this paper
• Dexamethasone Increases Cisplatin-Loaded Nanocarrier Delivery and Efficacy in Metastatic Breast Cancer by Normalizing the Tumor Microenvironment.

  2019cites this paper
• Neutralizing tumor-promoting inflammation with polypeptide-dexamethasone conjugate for microenvironment modulation and colorectal cancer therapy.

  2019cites this paper
• Glucocorticoids promote the development of azoxymethane and dextran sulfate sodium-induced colorectal carcinoma in mice

  2019cites this paper
• Evaluation of the mevalonate pathway as a target for the treatment of ovarian cancer

  2018cites this paper
• Functional Gene Knockout of NRF2 Increases Chemosensitivity of Human Lung Cancer A549 Cells In Vitro and in a Xenograft Mouse Model

  2018cites this paper
• Physiologically-based pharmacokinetic and pharmacodynamic models for gemcitabine and birinapant in pancreatic cancer xenografts

  2018cites this paper
• Lipopolysaccharide (LPS) enhances prostate cancer metastasis potentially through NF‐κB activation and recurrent dexamethasone administration fails to suppress it in vivo

  2018cites this paper
• Fasting regulates EGR1 and protects from glucose- and dexamethasone-dependent sensitization to chemotherapy

  2017cites this paper
• Adriamycin in combination with dexamethasone and octreotide lacks activity on the treatment of a 4T1 metastatic breast cancer model

  2017cites this paper
• A formulation of pancreatic pro-enzymes provides potent anti-tumour efficacy: a pilot study focused on pancreatic and ovarian cancer

  2017cites this paper
• Liposomal prednisolone phosphate potentiates the antitumor activity of liposomal 5-fluorouracil in C26 murine colon carcinoma in vivo

  2017cites this paper
• Pharmacokinetics and Pharmacodynamics-Based Mathematical Modeling Identifies an Optimal Protocol for Metronomic Chemotherapy.

  2017cites this paper
• Characterizing Gemcitabine Effects Administered as Single Agent or Combined with Carboplatin in Mice Pancreatic and Ovarian Cancer Xenografts: A Semimechanistic Pharmacokinetic/Pharmacodynamics Tumor Growth-Response Model

  2017cites this paper
• Glucocorticoid receptors in lung cancer: new perspectives.

  2016cites this paper
• Gemcitabine Mechanism of Action Confounds Early Assessment of Treatment Response by 3'-Deoxy-3'-[18F]Fluorothymidine in Preclinical Models of Lung Cancer.

  2016influential citation
• PHGDH Expression Is Required for Mitochondrial Redox Homeostasis, Breast Cancer Stem Cell Maintenance, and Lung Metastasis.

  2016cites this paper
• Inhibition of nuclear factor-kappa B enhances the tumor growth of ovarian cancer cell line derived from a low-grade papillary serous carcinoma in p53-independent pathway

  2016cites this paper
• Selective glucocorticoid receptor-activating adjuvant therapy in cancer treatments

  2016cites this paper
• Targeting Inflammation in Cancer Prevention and Therapy

  2016cites this paper
• Corticosteroids compromise survival in glioblastoma.

  2016cites this paper
• Meta-analysis of the effects of oral and intravenous dexamethasone premedication in the prevention of paclitaxel-induced allergic reactions

  2016cites this paper
• Do Corticosteroids Compromise Survival in Glioblastoma?

  2016cites this paper
• Minireview: Familiar Faces in Unfamiliar Places: The Emerging Role of Nuclear Receptors in Lung Cancer.

  2015cites this paper
• Title Glucocorticoids suppress renal cell carcinoma progression by enhancing Na , K-ATPase beta-1 subunit expression Permalink

  2015cites this paper
• Glucocorticoids Suppress Renal Cell Carcinoma Progression by Enhancing Na,K-ATPase Beta-1 Subunit Expression

  2015cites this paper
• Overview of Methods for Overcoming Hindrance to Drug Delivery to Tumors, with Special Attention to Tumor Interstitial Fluid

  2015cites this paper
• [Current applications of dexamethasone for cancer treatment].

  2015cites this paper
• Preclinical Murine Models for Lung Cancer: Clinical Trial Applications

  2015cites this paper
• Local iontophoretic administration of cytotoxic therapies to solid tumors

  2015cites this paper
• Platinum Compounds for High‐Resolution In Vivo Cancer Imaging

  2014cites this paper
• Pemetrexed and gemcitabine as combination therapy for the treatment of Group3 medulloblastoma.

  2014cites this paper
• Mathematical models for absorption and efficacy of ovarian cancer treatments

  2014cites this paper
• Therapeutic Modalities of Squalenoyl Nanocomposites in Colon Cancer: An Ongoing Search for Improved Efficacy

  2014cites this paper
• Simvastatin and Dexamethasone Potentiate Antitumor Activity of Fotemustine

  2014cites this paper
• Integrated Systems and Technologies Noninvasive Quanti fi cation of Solid Tumor Microstructure Using VERDICT MRI

  2014cites this paper
• Noninvasive quantification of solid tumor microstructure using VERDICT MRI.

  2014cites this paper
• Reactive Oxygen Species‐Scavenging Nanomedicines for the Treatment of Oxidative Stress Injuries

  2014cites this paper
• Redox nanoparticle therapeutics to cancer--increase in therapeutic effect of doxorubicin, suppressing its adverse effect.

  2013cites this paper
• Phase II randomized trial of carboplatin and gemcitabine with or without dexamethasone pre-treatment in patients with Stage IV non-small cell lung cancer

  2013cites this paper
• H-gemcitabine: a new gemcitabine prodrug for treating cancer.

  2013cites this paper
• Targeting the NF-κB pathway in cancer therapy.

  2013cites this paper
• Cancer targeting potential of folate targeted nanocarrier under comparative influence of tretinoin and dexamethasone.

  2013cites this paper
• The Critical Role of Mechanism-Based Models for Understanding and Predicting Liposomal Drug Loading, Binding and Release Kinetics

  2013cites this paper
• Cancer cell spheroids as a model to evaluate chemotherapy protocols

  2012cites this paper
• Dexamethasone Reduces Sensitivity to Cisplatin by Blunting p53-Dependent Cellular Senescence in Non-Small Cell Lung Cancer

  2012cites this paper
• High payload dual therapeutic-imaging nanocarriers for triggered tumor delivery.

  2012cites this paper
• Combination of Natural Drugs: An Emerging Trend in Cancer Chemotherapy

  2012cites this paper
• Synergistic effect of HPMA copolymer-bound doxorubicin and dexamethasone in vivo on mouse lymphomas

  2011cites this paper
• Glucocorticoid receptor and breast cancer

  2011influential citation
• Polymer Micelles with Hydrazone-Ester Dual Linkers for Tunable Release of Dexamethasone

  2011cites this paper
• Uniformity of drug payload and its effect on stability of solid lipid nanoparticles containing an ester prodrug.

  2011cites this paper
• Glucocorticoid Receptor Expression and Antiproliferative Effect of Dexamethasone on Human Melanoma Cells

  2011cites this paper
• Influence des hormones stéroïdes et potentiel préventif d'un antiprogestatif, l'ulpristal acétate, dans la tumorigenèse liée à la mutation du gène BRCA1

  2011cites this paper
• Endostar, a modified recombinant human endostatin, exhibits synergistic effects with dexamethasone on angiogenesis and hepatoma growth.

  2011cites this paper
• EVALUATION OF THE PHYSICOCHEMICAL PROPERTIES AND STABILITY OF SOLID LIPID NANOPARTICLES DESIGNED FOR THE DELIVERY OF DEXAMETHASONE TO TUMORS

  2011influential citation
• Inflammation and Cancer: Causes and Consequences

  2010cites this paper
• Inhibition of Ape1's DNA Repair Activity as a Target in Cancer: Identification of Novel Small Molecules that have Translational Potential for Molecularly Targeted Cancer Therapy

  2010cites this paper
• Activation of a nuclear factor of activated T‐lymphocyte‐3 (NFAT3) by oxidative stress in carboplatin‐mediated renal apoptosis

  2010cites this paper
• Intensive anti-inflammatory therapy with dexamethasone in patients with non-small cell lung cancer: effect on chemotherapy toxicity and efficacy

  2009influential citation
• Intravenous Paclitaxel Is Specifically Retained in Human Gynecologic Carcinoma Tissues In Vivo

  2009cites this paper
• Anti-Inflammatory Agents for Cancer Therapy.

  2009influential citation
• Cytosolic Phospholipase A2: Targeting Cancer through the Tumor Vasculature

  2009cites this paper
• The antitumoral effect of Paris Saponin I associated with the induction of apoptosis through the mitochondrial pathway

  2009cites this paper
• Nanoparticles Containing Anti-inflammatory Agents as Chemotherapy Adjuvants II: Role of Plasma Esterases in Drug Release

  2009cites this paper
• Antitumor activity of EGFR targeted pH-sensitive immunoliposomes encapsulating gemcitabine in A549 xenograft nude mice.

  2009cites this paper